TRIGR Therapeutics Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$50.3M
TRIGR Therapeutics General Information
Description
Developer of therapeutic drugs intended to treat cancer. The company's drug conserves the stability attributes of classic monoclonal antibody structure based on validated mechanisms of action and apparent differentiation, enabling medical companies to facilitate potentially safe and effective multi-targeted drugs.
Contact Information
Website
www.trigrrx.comCorporate Office
- 4790 Irvine Boulevard
- Suite 105-578
- Irvine, CA 92620
- United States
Corporate Office
- 4790 Irvine Boulevard
- Suite 105-578
- Irvine, CA 92620
- United States
TRIGR Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 25-Jun-2021 | $50.3M | Completed | Clinical Trials - Phase 2 | ||
| 1. Seed Round | 25-Mar-2019 | Completed | Clinical Trials - Phase 1 |
TRIGR Therapeutics Comparisons
Industry
Financing
Details
TRIGR Therapeutics Competitors (2)
One of TRIGR Therapeutics’s 2 competitors is Perthera, a Venture Capital-Backed company based in McLean, VA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Perthera | Venture Capital-Backed | McLean, VA | ||||
| AVEO Oncology | Formerly VC-backed | Boston, MA |
TRIGR Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TRIGR Therapeutics Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Handok | Corporation | Minority |
TRIGR Therapeutics FAQs
-
When was TRIGR Therapeutics founded?
TRIGR Therapeutics was founded in 2018.
-
Where is TRIGR Therapeutics headquartered?
TRIGR Therapeutics is headquartered in Irvine, CA.
-
What industry is TRIGR Therapeutics in?
TRIGR Therapeutics’s primary industry is Drug Discovery.
-
Is TRIGR Therapeutics a private or public company?
TRIGR Therapeutics is a Private company.
-
What is the current valuation of TRIGR Therapeutics?
The current valuation of TRIGR Therapeutics is .
-
What is TRIGR Therapeutics’s current revenue?
The current revenue for TRIGR Therapeutics is .
-
How much funding has TRIGR Therapeutics raised over time?
TRIGR Therapeutics has raised $14M.
-
Who are TRIGR Therapeutics’s investors?
Handok has invested in TRIGR Therapeutics.
-
Who are TRIGR Therapeutics’s competitors?
Perthera and AVEO Oncology are competitors of TRIGR Therapeutics.
-
When was TRIGR Therapeutics acquired?
TRIGR Therapeutics was acquired on 25-Jun-2021.
-
Who acquired TRIGR Therapeutics?
TRIGR Therapeutics was acquired by Compass Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
